newsfilter
← Latest News
GlobeNewswire·

Impel Pharmaceuticals to Participate in Upcoming Investor Conferences in September

SEATTLE, Sept. 06, 2022 (GLOBE NEWSWIRE) -- Impel Pharmaceuticals Inc. (NASDAQ:IMPL), a commercial-stage pharmaceutical company developing transformative therapies for people suffering from diseases with high unmet medical needs, with an initial focus